Summit trims size of offering:
This article was originally published in Clinica
Summit Technology is to scale back its public offering to 3.5 million shares, priced at $16.00. The Waltham, Massachusetts-based company, whose share price soared to more than $29.00 last month, following the FDA advisory panel recommendation for its LASIK vision correction laser, is presently trading at around the offer price. The company plans to use the funds to commercialise its LADAR radar eye tracking and narrow beam lens shaping technology. Initially it planned to offer four million shares.